DI BARTOLOMEO, MARIA CRISTINA
 Distribuzione geografica
Continente #
EU - Europa 1.241
AS - Asia 1.213
NA - Nord America 1.107
SA - Sud America 111
AF - Africa 55
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 1
Totale 3.735
Nazione #
US - Stati Uniti d'America 1.069
DE - Germania 502
CN - Cina 391
SG - Singapore 336
GB - Regno Unito 210
IT - Italia 151
VN - Vietnam 112
HK - Hong Kong 108
BD - Bangladesh 94
BR - Brasile 89
SE - Svezia 87
RU - Federazione Russa 68
FR - Francia 53
IN - India 42
CI - Costa d'Avorio 38
IE - Irlanda 37
NL - Olanda 35
FI - Finlandia 31
JP - Giappone 25
CA - Canada 23
ID - Indonesia 23
TR - Turchia 21
KR - Corea 14
ES - Italia 12
UA - Ucraina 12
IQ - Iraq 11
BE - Belgio 9
AR - Argentina 7
DK - Danimarca 7
EC - Ecuador 7
PL - Polonia 7
AU - Australia 6
NO - Norvegia 6
MX - Messico 5
PH - Filippine 4
AZ - Azerbaigian 3
DZ - Algeria 3
IR - Iran 3
JO - Giordania 3
KE - Kenya 3
PT - Portogallo 3
ZA - Sudafrica 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
AT - Austria 2
CH - Svizzera 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
HU - Ungheria 2
KZ - Kazakistan 2
LB - Libano 2
MY - Malesia 2
NP - Nepal 2
PE - Perù 2
TH - Thailandia 2
TN - Tunisia 2
TW - Taiwan 2
UY - Uruguay 2
UZ - Uzbekistan 2
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BS - Bahamas 1
BW - Botswana 1
CO - Colombia 1
DM - Dominica 1
EG - Egitto 1
ET - Etiopia 1
GE - Georgia 1
GY - Guiana 1
HN - Honduras 1
IS - Islanda 1
KG - Kirghizistan 1
LC - Santa Lucia 1
MA - Marocco 1
MN - Mongolia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PR - Porto Rico 1
PY - Paraguay 1
RO - Romania 1
SA - Arabia Saudita 1
SN - Senegal 1
SV - El Salvador 1
VE - Venezuela 1
XK - ???statistics.table.value.countryCode.XK??? 1
ZW - Zimbabwe 1
Totale 3.735
Città #
Frankfurt am Main 439
Singapore 180
Southend 177
Ashburn 170
Hong Kong 92
Chandler 86
San Jose 73
Milan 62
Beijing 55
New York 47
Dallas 40
Los Angeles 39
Abidjan 38
Fairfield 38
Dublin 37
Council Bluffs 36
Santa Clara 36
Hanoi 34
Ho Chi Minh City 34
Seattle 29
Wilmington 26
Hefei 25
Munich 25
Princeton 25
Bengaluru 21
Helsinki 20
Cambridge 19
Houston 19
Istanbul 19
Jakarta 19
Buffalo 17
Dearborn 17
Woodbridge 17
Ann Arbor 16
Lauterbourg 16
Nanjing 16
Shanghai 16
Tokyo 15
Moscow 14
Phoenix 14
Columbus 10
Guangzhou 10
São Paulo 10
Des Moines 9
The Dalles 9
Brussels 8
Chicago 8
Nuremberg 8
Shenyang 8
Toronto 8
Cangzhou 7
Jinan 7
Zhengzhou 7
Hangzhou 6
Mountain View 6
Oslo 6
Shenzhen 6
Tianjin 6
Wuhan 6
Amsterdam 5
Atlanta 5
Brasília 5
Da Nang 5
Grafing 5
Hebei 5
Hyderabad 5
San Diego 5
Seoul 5
Stockholm 5
Sydney 5
Turku 5
Warsaw 5
Brooklyn 4
Chennai 4
Denver 4
Düsseldorf 4
Falls Church 4
Montreal 4
Naples 4
Rome 4
San Francisco 4
Shijiazhuang 4
Taizhou 4
Urbino 4
Amman 3
Baku 3
Bến Tre 3
Central District 3
Changsha 3
Chongqing 3
Guayaquil 3
Handan 3
Hải Dương 3
Kent 3
Lanzhou 3
Manchester 3
McAllen 3
Mexico City 3
Newark 3
Ningbo 3
Totale 2.424
Nome #
Perioperative Bevacizumab-based Triplet Chemotherapy in Patients with Potentially Resectable Colorectal Cancer Liver Metastases 316
DPD and UGT1A1 deficiency in colorectal cancer patients receiving triplet chemotherapy with fluoropyrimidines, oxaliplatin and irinotecan 269
Prognostic impact of early tumor shrinkage and depth of response in patients with microsatellite instability-high metastatic colorectal cancer receiving immune checkpoint inhibitors 263
Maintenance Therapy with Panitumumab Alone vs Panitumumab Plus Fluorouracil-Leucovorin in Patients with RAS Wild-Type Metastatic Colorectal Cancer: A Phase 2 Randomized Clinical Trial 252
Emergence of MET hyper-amplification at progression to MET and BRAF inhibition in colorectal cancer 249
ALK Inhibitors in Patients With ALK Fusion-Positive GI Cancers: An International Data Set and a Molecular Case Series 229
First-line anti-EGFR monoclonal antibodies in panRAS wild-type metastatic colorectal cancer : a systematic review and meta-analysis 227
Bax expression is predictive of favorable clinical outcome in chemonaive advanced gastric cancer patients treated with capecitabine, oxaliplatin, and irinotecan regimen 219
Single-agent panitumumab in frail elderly patients with advanced RAS and BRAF wild-type colorectal cancer : challenging drug label to light up new hope 216
Impact of early tumor shrinkage and depth of response on the outcomes of panitumumab-based maintenance in patients with RAS wild-type metastatic colorectal cancer 211
Reinduction of an Anti-EGFR-based First-line Regimen in Patients with RAS Wild-type Metastatic Colorectal Cancer Enrolled in the Valentino Study 207
Preoperative Capecitabine, Oxaliplatin, and Irinotecan in Resectable Gastric or Gastroesophageal Junction Cancer: Pathological Response as Primary Endpoint and FDG-PET Predictions 194
A review on biomarkers for prediction of treatment outcome in gastric cancer 190
Transcriptional and epigenetic phenomena in peripheral blood cells of monozygotic twins discordant for Alzheimer’s disease, a case report 175
Systemic doxycycline for pre-emptive treatment of anti-EGFR-related skin toxicity in patients with metastatic colorectal cancer receiving first-line panitumumab-based therapy: a post hoc analysis of the Valentino study 175
Prognostic value of diffuse versus intestinal histotype in patients with gastric cancer : a systematic review and meta-analysis 152
Translating knowledge into policy: Organizational model and minimum requirements for the implementation of a regional pancreas unit network 116
Impact of Metformin Use and Diabetic Status During Adjuvant Fluoropyrimidine-Oxaliplatin Chemotherapy on the Outcome of Patients with Resected Colon Cancer: A TOSCA Study Subanalysis 95
The potential role of metformin in the treatment of patients with pancreatic neuroendocrine tumors: a review of preclinical to clinical evidence 84
Totale 3.839
Categoria #
all - tutte 9.868
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.868


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202132 0 0 0 0 0 0 0 0 0 0 17 15
2021/2022229 17 18 17 8 12 20 11 8 19 32 16 51
2022/2023290 31 40 29 24 17 61 7 16 39 1 18 7
2023/2024519 9 11 17 22 73 21 63 63 31 61 71 77
2024/2025757 57 76 51 90 41 41 41 52 27 75 69 137
2025/20261.462 159 120 146 140 118 73 210 35 127 106 228 0
Totale 3.839